Jan 3, 2020
Importance of the Issue: The way ahead for Virginia means inclusion and opportunity for all Virginians, including individuals with disabilities. An estimated one in ten Virginians have a disability.1 The Americans with Disabilities Act of 1990 defines disability as...
Dec 27, 2019
Just like physical symptoms of Multiple Sclerosis, cognitive symptoms result from damage to the myelin covering of nerve fibers in the brain and the nerve fibers themselves. Since the areas of damage are different in different people, the effects on cognition vary...
Nov 10, 2019
In a news release dated March 26, 2019, the United States Food and Drug Administration (FDA) announced the approval of Mayzent® (siponimod) oral tablets to treat adults with relapsing forms of multiple sclerosis (MS). The approval includes individuals with clinically...
Nov 10, 2019
The U.S. Food and Drug Administration (FDA) has approved Vumerity (diroximel fumarate) for the treatment of relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), and active secondary progressive...
Nov 5, 2019
The definition of spasticity reads like a description from a medical school textbook, but the National Multiple Sclerosis Society (NMSS) calls it a “feeling of stiffness” as well as “involuntary muscle spasms” or “sustained muscle contractions or sudden movements.”...
Nov 5, 2019
Multiple sclerosis (MS) is a disease of tremendous variability, but the most common — and often most debilitating — symptom of MS is fatigue. Unlike “ordinary” tiredness, fatigue in multiple sclerosis is disproportionate to the activity being performed. And it’s not...
